Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
The European Journal of Health Economics
Erschienen in: The European Journal of Health Economics 5/2012

01.10.2012 | Original Paper

Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain’s Economy?

verfasst von: Juan Oliva-Moreno

Erschienen in: The European Journal of Health Economics | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to estimate the economic impact of the non-medical costs of diseases and accidents in Spain. Its main premise sustains the idea that in addition to the number of deaths, the loss of quality of life and the pain suffered by patients and their family members as a result of diseases and accidents, there are other indicators that provide us with a better understanding of their socioeconomic impact. Our analysis provides estimates of the loss of labour productivity in Spain as a result of health problems in 2005. Our main finding suggests an estimated loss amounting to over 37,969 millions euros, of which 9,136 millions euros are due to premature deaths, 18,577 millions to permanent disability and 10,255 millions to temporary disability. The loss in labour productivity due to accidents and health problems was estimated to a figure equivalent to nearly 4.2% of the Gross Domestic Product of Spain in 2005. This study underscores the strong economic impact of non-medical costs of diseases. In addition, it stresses the need for better information systems for collecting data that is relevant to the topic at hand.
Literatur
1.
Suhrcke, M., McKee, M., Sauto Arce, R., Tsolova, S., Mortensen, J.: The contribution of health to the economy in the European Union. European Commission, Brussels (2005)
2.
Commission of the European Communities: White Paper-Together for Health: A Strategic Approach for the EU 2008–2013. Brussels, 23.10.2007
3.
Becker, G.S.: Human Capital. Columbia University Press, Chicago (1964)
4.
Ben-Porath, Y.: The production of human capital and the life cycle of earnings. J. Polit. Econ. 75(4 Part 1), 352–365 (1967)CrossRef
5.
Mincer, J.: Schooling, Experience, and Earnings. Human Behavior and Social Institutions. Columbia University Press, New York (1974)
6.
Fuchs, V.R.: The contribution of health services to the American economy. Milbank Meml. Fund Q. 44, 65–102 (1966)CrossRef
7.
Grossman, M.: On the concept of health capital and the demand for health. J. Polit. Econ. 80(2), 223–255 (1972)CrossRef
8.
Grossman, M.: The human capital model of the demand for health. In: Culyer, A.J., Newhouse, J.P. (eds.). Handbook of Health Economics. North-Holland (2000)
9.
10.
National Institutes of Health: National Heart, Lung and Blood Institute. Fact Book. Fiscal Year 2005 (2006)
11.
Minister of Public Works and Government Services Canada: Economic Burden of Illness in Canada, 1998. Ottawa, Ontario (2002)
12.
Jarl, J., Johansson, P., Eriksson, A., Eriksson, M., Gerdtham, U.G., Hemström, O., Selin, K.H., Lenke, L., Ramstedt, M., Room, R.: The societal cost of alcohol consumption an estimation of the economic and human cost including health effects in Sweden, 2002. Eur. J. Health Econ. 9(4), 351–360 (2008)PubMedCrossRef
13.
Johannesson, M.: The willingness to pay for health changes, the human-capital approach and the external costs. Health Policy 36, 232–244 (1996)CrossRef
14.
Johannesson, M., Jönsson, B., Karlsson, G.: Outcome measurement in economic evaluation. Health Econ. 5, 279–296 (1996)PubMedCrossRef
15.
Lidgren, M., Wilking, N., Jönsson, B.: Cost of breast cancer in Sweden in 2002. Eur. J. Health Econ. 8(1), 5–15 (2007)PubMedCrossRef
16.
Oliva-Moreno, J., López Bastida, J., Montejo, A.L., Osuna, R., Duque, B.: The socioeconomic costs of mental illness in Spain. Eur. J. Health Econ. 10(4), 361–369 (2009)PubMedCrossRef
17.
Koopmanschap, M.A., van Ineveld, B.M.: Towards a new approach for estimating indirect costs of disease. Soc. Sci. Med. 34, 1005–1010 (1992)PubMedCrossRef
18.
Koopmanschap, M.A., Rutten, F.H., van Ineveld, B.M., van Roijen, B.M.: The friction cost method for measuring indirect cost of disease. J Health Econ. 14, 171–189 (1995)PubMedCrossRef
19.
Koopmanschap, M.A., Rutten, F.F.H.: A practical guide for calculating indirect costs of disease. Pharmacoeconomics 10(5), 460–466 (1997)CrossRef
20.
Johannesson, M., Karlsson, G.: The friction cost method: a comment. J. Health Econ. 16, 249–255 (1997)PubMedCrossRef
21.
Liljas, B.: How to calculate indirect costs in economic evaluation. Pharmacoeconomics 13, 1–7 (1998)PubMedCrossRef
22.
Hutubessy, R.C., van Tulder, M.W., Vondeling, H., Bouter, L.M.: Indirect costs of back pain in The Netherlands: a comparison of the human capital method with the friction cost method. Pain 80, 201–207 (1999)PubMedCrossRef
23.
Oliva, J., Lobo, F., Lopez-Bastida, J., Zozaya, N., Romay, R.: Indirect costs of cervical and breast cancer in Spain. Eur. J. Health Econ. 6, 309–313 (2005)PubMedCrossRef
24.
Lofland, J.H., Lock lear, J.C., Frick, K.D.: Different approaches to valuing the lost productivity of patients with migraine. Pharmacoeconomics 19, 917–925 (2001)PubMedCrossRef
25.
Marcotte, D.E., Wilcox-Gok, V.: Estimating the employment and earnings costs of mental illness: recent developments in the United States. Soc. Sci. Med. 53, 21–27 (2001)PubMedCrossRef
26.
Zhang, W., Bansback, N., Anis, A.H.: Measuring and valuing productivity loss due to poor health: a critical review. Soc. Sci. Med. 72(2), 185–192 (2011)PubMedCrossRef
27.
Wieser, S., Horisberger, B., Schmidhauser, S., Eisenring, C., Brügger, U., Ruckstuhl, A., Dietrich, J., Mannion, A.F., Elfering, A., Tamcan, O., Müller, U.: Cost of low back pain in Switzerland in 2005. Eur. J. Health Econ. (2010)
28.
Instituto Nacional de la Salud: Memoria de las actividades desarrolladas por las unidades de valoración médica de incapacidades, Madrid: INSALUD (1994)
29.
Arancón Viguera, A.: Estudio epidemiológico sobre la incapacidad permanente para el trabajo. Medicina General 45, 462–470 (2002)
30.
Agudelo-Suárez, A.A., Benavides, F.G., Felt, E., Ronda-Pérez, E., Vives-Cases, C., García, A.M.: Sickness presenteeism in Spanish-born and immigrant workers in Spain. BMC Public Health 10, 791 (2010)PubMedCrossRef
31.
Pauly, M.V., Nicholson, S., Polsky, D., Berger, M.L., Sharda, C.: Valuing reductions in on-the-job illness: ‘presenteeism’ from managerial and economic perspectives. Health Econ. 17(4), 469–485 (2008)PubMedCrossRef
32.
Finkelstein, E.A., DiBonaventura, M., Burgess, S.M., Hale, B.C.: The costs of obesity in the workplace. J. Occup. Environ. Med. 52(10), 971–976 (2010)PubMedCrossRef
33.
Oliva, J., Osuna, R.: Los costes de los cuidados informales en España. Presupuesto y Gasto Público 56, 163–181 (2009)
34.
Hu, T.W.: Perspectives: an international review of the national cost estimates of mental illness, 1990–2003. J. Ment. Health Policy Econ. 9(1), 3–13 (2006)PubMed
35.
Leal, J., Luengo-Fernández, R., Gray, A., Petersen, S., Rayner, M.: Economic burden of cardiovascular diseases in the enlarged European Union. Eur. Heart J. 27(13), 1610–1619 (2006)PubMedCrossRef
36.
Sobocki, P., Jönsson, B., Angst, J., Rehnberg, C.: Cost of depression in Europe. J. Ment. Health Policy Econ. 9(2), 87–98 (2006)PubMed
37.
Cutler, D.: The lifetime costs and benefits of medical technology. J. Health Econ. 26(6), 1081–1100 (2007)PubMedCrossRef
38.
Cutler, D., Rosen, A.B., Vijan, S.: Value of medical innovation in the United States: 1960–2000. New Engl. J. Med. 355, 920–927 (2006)PubMedCrossRef
39.
Health Economics Research Group, Office of Health Economics, RAND Europe: Medical Research: What’s it worth? Estimating the economic benefits from medical research in the UK. London: UK Evaluation Forum (2008)
40.
Sachs JD (chair) Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics and Health. World Health Organization, Geneva, Switzerland (2001)
41.
Knapp, M.: Hidden costs of mental illness. Br. J. Psychiatr. 183, 477–478 (2003)CrossRef
42.
Sánchez Martínez FI, Abellán Perpiñán JM, Martínez Pérez JE: How should health and healthcare priorities be set and evaluated? Prioritization methods and regional disparities. 2008 SESPAS Report. Gac Sanit. 22(Supl 1):126–136 (2008)
Metadaten
Titel
Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain’s Economy?
verfasst von
Juan Oliva-Moreno
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
The European Journal of Health Economics / Ausgabe 5/2012
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-011-0344-9

Weitere Artikel der Ausgabe 5/2012

The European Journal of Health Economics 5/2012 Zur Ausgabe

Original Paper

The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country

Original Paper

Medical guidelines, physician density, and quality of care: evidence from German SHARE data

Original Paper

Disease progression and costs of care in Alzheimer’s disease patients treated with donepezil: a longitudinal naturalistic cohort

Original Paper

Genetic testing in the European Union: does economic evaluation matter?

Original Paper

Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale

Original Paper

Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab